Article
Monitoring of tisagenlecleucel transgene DNA using a quantitative polymerase chain reaction assay
10 Dec 2020
Abstract excerpt
Chimeric antigen receptor (CAR)-T cell therapies reprogram T cells to engage and eliminate cancer cells. Patients' T cells are transduced in vitro using lentiviral or retroviral vectors containing a CAR transgene. Following infusion, CAR-T cells expand in vivo and may persist in the peripheral blood and bone marrow for years. Therefore, monitoring in vivo copies of the CAR transgene requires highly sensitive,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
